NIH 2020 R42 AI |
Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant bacteremia Kraus, Carl / Arrevus, Inc. |
|
NIH 2019 R42 AI |
Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant bacteremia Kraus, Carl / Arrevus, Inc. |
|
NIH 2018 R42 AI |
Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant bacteremia Kraus, Carl / Arrevus, Inc. |
|